spacer
The Healthcare Sales & Marketing Network celebrates 27 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  Benign Prostatic Hyperplasia 

 HSMN NewsFeed - 10 Oct 2024
Rivermark Medical Closes $30 Million Series C Financing to Advance Development of Flostent(TM) System for Benign Prostatic Hyperplasia
Devices Urology Venture Capital
 HSMN NewsFeed - 20 Mar 2024
ProVerum Announces Completion of Enrollment for the ProVIDE Clinical Study for BPH and First-use of its New Flexible, Steerable Delivery System
Devices Interventional Urology
 HSMN NewsFeed - 27 Oct 2023
Laborie Medical Technologies Acquires Urotronic
Devices Urology Mergers & Acquisitions
 HSMN NewsFeed - 16 Mar 2023
Embolx Signs International Distribution Agreement
Devices Interventional Distribution
 HSMN NewsFeed - 13 Oct 2021
Varian Receives FDA "Breakthrough Device Designation" For Embozene(R) Microspheres For Genicular Artery Embolization For Symptomatic Knee Osteoarthritis
Devices Interventional FDA
 HSMN NewsFeed - 24 Feb 2021
Clarus Therapeutics Appoints Richard 'Ric' Peterson as Chief Financial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 23 Sep 2020
New Treatment for Urethral Strictures, Optilume(R), Receives CE Approval
Devices Urology Regulatory
 HSMN NewsFeed - 30 Aug 2019
Sophiris Bio Announces Completion of $4.0 Million Registered Direct Offering
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 13 Aug 2019
Corinth MedTech Appoints Steven Duddy as New President and CEO
Devices Urology Personnel
 HSMN NewsFeed - 15 Mar 2019
Lumenis Announces New Clinical Breakthroughs Using Its Patent-Protected MOSES(TM) Technology
Devices Urology
 HSMN NewsFeed - 25 Jan 2019
New Four-Year Data Demonstrate Rezūm(TM) Water Vapor Therapy Offers Significant Durable Improvement of Benign Prostatic Hyperplasia Symptoms
Devices Urology
 HSMN NewsFeed - 30 Apr 2018
Boston Scientific Closes NxThera Acquisition
Devices Urology Mergers & Acquisitions
 HSMN NewsFeed - 21 Mar 2018
Boston Scientific Announces Agreement To Acquire NxThera
Devices Urology Mergers & Acquisitions
 HSMN NewsFeed - 20 Nov 2017
United Therapeutics Announces Additional Six Months Of Regulatory Exclusivity For Adcirca(R)
Biopharmaceuticals FDA Licensing
 HSMN NewsFeed - 23 Mar 2017
Revolutionary UroLift(R) System Launches in Ireland
Devices Urology Product Launch
 HSMN NewsFeed - 15 Nov 2016
Boston Scientific Acquires Resectr(TM) Tissue Resection Device from Distal Access, LLC
Devices Surgery Acquisitions
 HSMN NewsFeed - 14 Mar 2016
The European Association of Urology Upgrades UroLift(R) System Trial Data to its Highest Possible Classification - Level 1A - in its Guidelines
Devices Urology
 HSMN NewsFeed - 12 Oct 2015
Teva Announces Exclusive Launch of Generic Avodart(R) Capsules in the United States
Biopharmaceuticals Urology Generics Product Launch
 HSMN NewsFeed - 4 Aug 2015
Boston Scientific Closes Acquisition Of The American Medical Systems Male Urology Portfolio
Devices Urology Acquisitions
 HSMN NewsFeed - 2 Mar 2015
Boston Scientific Announces Definitive Agreement To Acquire American Medical Systems' Urology Portfolio For Up To $1.65 Billion
Devices Urology Mergers & Acquisitions
 HSMN NewsFeed - 10 Nov 2014
NeoTract, Inc. Announces CMS Reimbursement for Innovative Minimally Invasive Procedure for Enlarged Prostate
Devices Urology Reimbursement
 HSMN NewsFeed - 20 Mar 2014
Sophiris Adds Gerald T. Proehl to its Board of Directors
Biopharmaceuticals Urology Personnel
 HSMN NewsFeed - 13 Mar 2014
NeoTract's UroLift(R) Implant Procedure for Men with Enlarged Prostate Receives Medicare and Medicaid Outpatient Billing Codes for Reimbursement
Devices Urology Reimbursement
 HSMN NewsFeed - 9 Dec 2013
American Medical Systems Receives FDA 510(k) Clearance of the RetroArc(TM) Retropubic Sling System for Treatment of Female Stress Urinary Incontinence
Devices FDA
 HSMN NewsFeed - 24 Sep 2013
First U.S. Patient Treated Following FDA Clearance of NeoTract's UroLift(R) System
Devices Urology Product Launch
 HSMN NewsFeed - 4 Sep 2013
Bard Announces Agreement to Acquire Rochester Medical, Inc.
Devices Urology Mergers & Acquisitions
 HSMN NewsFeed - 23 Aug 2013
Sophiris Bio Closes $65 Million Public Offering
Biopharmaceuticals Urology Venture Capital
 HSMN NewsFeed - 9 Aug 2013
Medifocus, Inc. Announces the Initiation of Its Principal Investigational Site in Canada for Its Pivotal Phase III Clinical Trial for Breast Cancer Treatment
Devices Oncology
 HSMN NewsFeed - 19 Jun 2013
Actavis And Kissei File Lawsuits Against Sandoz And Hetero For Infringement Of Rapaflo(R) Patent
Biopharmaceuticals Urology Generics Litigation
 HSMN NewsFeed - 4 Jun 2013
First Head-to-Head Study Shows Greenlight XPS(R) Laser Therapy Equally Safe and Effective with Faster Recovery as Commonly Used Turp for Treatment of BPH
Devices Urology
 HSMN NewsFeed - 23 May 2013
Astellas Receives Marketing Authorization for VESOMNI(TM) from the Netherlands Medicines Evaluation Board
Biopharmaceuticals Urology Regulatory
 HSMN NewsFeed - 7 Mar 2013
Merit Medical Receives CE Mark for Prostatic Artery Embolization for Embosphere(R) Microspheres
Devices Urology Regulatory
 HSMN NewsFeed - 30 Jan 2013
Urologix Names Greg Fluet as New CEO
Devices Urology Personnel
 HSMN NewsFeed - 20 Dec 2012
Robert S. Cowles, III, M.D. Joins Urodyne, Inc. and Hyperdyne, Inc., Two Subsidiaries Trimedyne Plans to Organize, as Co-Chairman and Medical Director
Devices Surgery Personnel
 HSMN NewsFeed - 30 Oct 2012
European Commission approves Cialis(R) (tadalafil) tablets for the treatment of the signs and symptoms of benign prostatic hyperplasia
Biopharmaceuticals Urology Regulatory
 HSMN NewsFeed - 21 Sep 2012
Cialis(R) (tadalafil) Tablets Recommended for Approval for the Treatment of the Signs and Symptoms of Benign Prostatic Hyperplasia in the European Union
Biopharmaceuticals Urology Regulatory
 HSMN NewsFeed - 31 Aug 2012
Sophiris' Drug for Benign Prostatic Hyperplasia was Well Tolerated Using the Preferred Transrectal Route of Administration
Biopharmaceuticals Urology
 HSMN NewsFeed - 18 Jul 2012
Endo Health Solutions Names New President of American Medical Systems
Devices Urology Personnel
 HSMN NewsFeed - 7 Feb 2012
New Study Evaluates Cialis(R) in parallel with Tamsulosin in Men with Signs and Symptoms Suggestive of Benign Prostatic Hyperplasia
Biopharmaceuticals Urology
 HSMN NewsFeed - 7 Oct 2011
Cialis(R) for Once Daily Use Now FDA-Approved to Treat Men With Signs and Symptoms of Benign Prostatic Hyperplasia (BPH) and Men With Both Erectile Dysfunction (ED) and Signs and Symptoms of BPH
Biopharmaceuticals FDA
 HSMN NewsFeed - 11 Apr 2011
Endo Announces Agreement to Acquire American Medical Systems for $2.9 Billion
Biopharmaceuticals Devices Mergers & Acquisitions
 HSMN NewsFeed - 13 Jan 2011
Trimedyne Announces a Settlement and Patent License Agreement With Lumenis Ltd.
Devices Litigation Licensing
 HSMN NewsFeed - 10 Aug 2010
Urologix Announces Election of Christopher R. Barys as Director
Devices Urology Personnel
 HSMN NewsFeed - 16 Jul 2010
Sun Pharma Announces USFDA Approval for Generic Flomax(R)
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 7 May 2010
Recordati Signs an Agreement With Zambon for the Co-Marketing of Silodosin in France
Biopharmaceuticals Urology Licensing
 HSMN NewsFeed - 28 Apr 2010
Teva Announces Launch of Generic Flomax(R)
Biopharmaceuticals Generics Urology FDA
 HSMN NewsFeed - 28 Apr 2010
Mylan Receives Approval for Generic Version of Flomax(R)
Biopharmaceuticals Generics Urology FDA
 HSMN NewsFeed - 1 Apr 2010
Allergan and Serenity Pharmaceuticals Enter into Global Agreement for the Treatment of Nocturia
Biopharmaceuticals Urology
 HSMN NewsFeed - 2 Mar 2010
Impax Laboratories Receives Final FDA Approval for Generic FLOMAX(R) 0.4mg Capsules and Immediately Commences Shipment
Biopharmaceuticals FDA Generics
 HSMN NewsFeed - 3 Feb 2010
Silodosin (Urorec(R)/Silodyx) Approved by the European Commission for the Treatment of the Signs and Symptoms of BPH (Benign Prostatic Hyperplasia)
Biopharmaceuticals Urology Regulatory
 HSMN NewsFeed - 18 Dec 2009
Aeterna Zentaris Announces Termination of Agreement with sanofi-aventis U.S. for the Development, Commercialization and Licensing of Cetrorelix in Benign Prostatic Hyperplasia
Biopharmaceuticals Urology
 HSMN NewsFeed - 9 Dec 2009
New Published Data Demonstrate Long-Term Safety, Efficacy and Tolerability of Watson's RAPAFLO(R) (silodosin) for Benign Prostatic Hyperplasia (BPH) Symptom Relief
Biopharmaceuticals Urology
 HSMN NewsFeed - 7 Dec 2009
AEterna Zentaris Announces Results from its European Phase 3 Study with Cetrorelix in Benign Prostatic Hyperplasia
Biopharmaceuticals Urology
 HSMN NewsFeed - 23 Nov 2009
Light Sciences Oncology Elects Akbar Seddigh, Chairman of Elekta AB to Its Board of Directors
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 23 Nov 2009
Urodynamix Technologies Ltd. Provides Update on US Reimbursement
Devices Urology Reimbursement
 HSMN NewsFeed - 5 Oct 2009
Impax Laboratories Receives Tentative FDA Approval for Generic FLOMAX(R) 0.4mg Capsules
Biopharmaceuticals Urology Generics FDA
 HSMN NewsFeed - 29 Sep 2009
New Clinical Data Shows AMS' Minimally Invasive Treatment Options Effective at Restoring Female Pelvic Health
Devices Urology
 HSMN NewsFeed - 9 Sep 2009
TURis Plasma Vaporization Electrode from Olympus Revolutionizes the Therapy of Benign Prostatic Hyperplasia
Devices Urology
 HSMN NewsFeed - 8 Sep 2009
American Medical Systems Expands Gold-Standard AMS 800(R) Artificial Urinary Sphincter Line
Devices Urology
 HSMN NewsFeed - 17 Aug 2009
AEterna Zentaris Announces Results from Two Phase 3 Studies with Cetrorelix in Benign Prostatic Hyperplasia
Biopharmaceuticals Urology
 HSMN NewsFeed - 21 May 2009
Watson Launches GELNIQUE(TM) (oxybutynin chloride) Gel 10%, First and Only Topical Gel for Overactive Bladder (OAB)
Biopharmaceuticals Urology
 HSMN NewsFeed - 8 May 2009
RAPAFLO(TM) (silodosin) Provides Rapid and Sustained Benign Prostatic Hyperplasia (BPH) Symptom Relief in as Little as Three Days
Biopharmaceuticals Urology
 HSMN NewsFeed - 5 May 2009
Neurocrine Announces Work Force Restructuring
Biopharmaceuticals
 HSMN NewsFeed - 28 Apr 2009
Data Presented at AUA Demonstrate PROVENGE Significantly Prolongs Survival for Men With Advanced Prostate Cancer in Pivotal Phase 3 IMPACT Study
Biopharmaceuticals Oncology
 HSMN NewsFeed - 23 Apr 2009
Urologix Announces Launch of New Catheter and Scientific Presentations at 2009 American Urological Association Annual Meeting
Devices Urology
 HSMN NewsFeed - 23 Apr 2009
Lumenis Introduces the HoLEP Simulator and the PolyScope Disposable Ureteroscope at American Urology Association 2009 Annual Meeting
Devices Urology
 HSMN NewsFeed - 14 Apr 2009
PROVENGE Significantly Prolongs Survival in Men With Advanced Prostate Cancer in Pivotal Phase 3 IMPACT Study
Biopharmaceuticals Oncology
 HSMN NewsFeed - 7 Apr 2009
Watson Announces United States Availability of RAPAFLO(TM) (silodosin), a Novel New Treatment in Benign Prostatic Hyperplasia (BPH)
Biopharmaceuticals Urology
 HSMN NewsFeed - 6 Mar 2009
Sanofi-aventis and AEterna Zentaris Sign Agreement in the U.S.
Biopharmaceuticals Licensing Urology
 HSMN NewsFeed - 6 Mar 2009
AEterna Zentaris and Sanofi-Aventis Sign a Development, Commercialization and Licensing Agreement for Cetrorelix in Benign Prostatic Hyperplasia
Biopharmaceuticals Licensing Urology
 HSMN NewsFeed - 27 Jan 2009
Watson's GELNIQUE(TM) (oxybutynin chloride) Gel 10% Approved by FDA for the Treatment of Overactive Bladder
Biopharmaceuticals Drug Delivery Urology FDA
 HSMN NewsFeed - 12 Jan 2009
Allium Group Receives CE Mark for Its Next-Generation Prostatic Stent
Devices Urology Interventional Regulatory
 HSMN NewsFeed - 22 Oct 2008
Mylan Receives Tentative FDA Approval for First-to-File Generic Version of Blood Pressure Drug Benicar HCT(R)
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 8 Oct 2008
Watson Receives US FDA Approval for RAPAFLO(TM) (silodosin) for the Treatment of Benign Prostatic Hyperplasia (BPH)
Biopharmaceuticals FDA Urology
 HSMN NewsFeed - 12 Aug 2008
AEterna Zentaris Announces Appointment of Prof. Jurgen Engel, Ph.D. as New President and CEO
Biopharmaceuticals Personnel
 HSMN NewsFeed - 17 Jul 2008
BSD Medical Responds to FDA On Its BSD-2000 PMA Application
Devices Oncology Urology FDA
 HSMN NewsFeed - 15 Jul 2008
Light Sciences Oncology Raises $40.1 Million in Series C Financing
Devices Oncology Venture Capital
 HSMN NewsFeed - 7 Jul 2008
Light Sciences Oncology Begins Clinical Trials of Litx Therapy in Patients with Enlarged Prostate
Devices Urology
 HSMN NewsFeed - 24 Jun 2008
Urologix Announces Appointment of CEO and Director
Devices Urology Personnel
 HSMN NewsFeed - 21 May 2008
Watson Announces Positive Data for Its New Investigational Products for Benign Prostatic Hyperplasia and Overactive Bladder
Biopharmaceuticals Urology
 HSMN NewsFeed - 16 May 2008
Urologix Launches New CTC Advance Catheter at 2008 American Urological Association Annual Meeting
Devices Urology
 HSMN NewsFeed - 6 May 2008
GTx Appoints Kenneth S. Robinson, MD to the Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 11 Apr 2008
AEterna Zentaris Announces Changes to its Management Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 26 Mar 2008
Aeterna Zentaris Begins Second Phase 3 Trial of Cetrorelix for Benign Prostatic Hyperplasia
Biopharmaceuticals Urology
 HSMN NewsFeed - 3 Mar 2008
GTx Announces Additional Top Line Phase III Data Demonstrating Toremifene Citrate 80 mg Reduced Hot Flashes in Men with Prostate Cancer on Androgen Deprivation Therapy
Biopharmaceuticals Oncology
 HSMN NewsFeed - 25 Feb 2008
Urologix Announces Leadership Changes
Devices Urology Personnel
 HSMN NewsFeed - 25 Feb 2008
GTx's Toremifene Citrate 80 mg Meets Primary and Key Endpoints in Phase III Trial in Advanced Prostate Cancer Patients on Androgen Deprivation Therapy
Biopharmaceuticals Oncology
 HSMN NewsFeed - 6 Feb 2008
Medtronic Receives U.S. FDA Approval for New Neurostimulator with Innovative Patient Programmer
Devices Neurology Pain Management FDA
 HSMN NewsFeed - 31 Jan 2008
Teva Announces Tentative Approval of Generic Flomax(R) Capsules
Biopharmaceuticals Urology Generics FDA
 HSMN NewsFeed - 18 Jan 2008
Enlarged Prostate Treatment Study Shows Combination of AVODART(R) and Tamsulosin Provides Greater Benefit Than Either Medication Alone
Biopharmaceuticals Urology
 HSMN NewsFeed - 7 Jan 2008
Watson Announces Positive Results From Its Pivotal Study of Oxybutynin Topical Gel for the Treatment of Overactive Bladder
Biopharmaceuticals Urology
 HSMN NewsFeed - 7 Jan 2008
BSD Medical Receives Letter from FDA on BSD-2000 Submission
Devices FDA
 HSMN NewsFeed - 7 Jan 2008
American Medical Systems Announces Resignation of Chief Executive Officer
Devices Personnel
 HSMN NewsFeed - 20 Nov 2007
Ranbaxy Launches Ran(R)-Tamsulosin Hydrochloride Capsules in Canada
Biopharmaceuticals Generics Regulatory
 HSMN NewsFeed - 14 Nov 2007
Protox collaborates with BrainLAB for Brain Cancer Program
Devices Neurosurgery
 HSMN NewsFeed - 8 Nov 2007
Ranbaxy and Astellas/Boehringer Ingelheim Enter Into an Agreement to Resolve Tamsulosin U.S. Patent Litigation
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 8 Nov 2007
Astellas and Boehringer Ingelheim Reach Settlement Agreement with Ranbaxy on Flomax Patent Case
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 1 Nov 2007
Medtronic Initiates Long-Term, Post-Market Study with InterStim(R) Therapy for Overactive Bladder
Devices Urology Neurology
 HSMN NewsFeed - 15 Oct 2007
Dong-A PharmTech Signs Licensing Deal With Otechestvennye to Market Zydena in Russia
Biopharmaceuticals Licensing
 HSMN NewsFeed - 8 Oct 2007
Clinical Study of American Medical Systems' Female Stress Urinary Incontinence Product Wins Top Honors
Devices Urology
 HSMN NewsFeed - 25 Sep 2007
Barr Confirms Patent Challenge of UROXATRAL(R)
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 19 Sep 2007
Allergan, Inc. Announces Agreement to Acquire Esprit Pharma, Inc.
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 14 Sep 2007
Study Shows Medtronic Neurostimulation Therapy Improves Chronic Neuropathic Leg and Back Pain
Devices
 HSMN NewsFeed - 4 Sep 2007
Study Shows Combination Therapy Incorporating AVODART(R) and Tamsulosin Provides Continuous Symptom Improvement Over 2 Years
Biopharmaceuticals Urology
 HSMN NewsFeed - 23 Aug 2007
Experienced Sales and Marketing Executive Rejoins Urologix
Devices Urology Personnel
 HSMN NewsFeed - 17 Jul 2007
Light Sciences Oncology Initiates Phase III Trial of Its Light Infusion Therapy (Litx(TM)) in Patients with Metastatic Colorectal Cancer
Biopharmaceuticals Devices Oncology
 HSMN NewsFeed - 26 Jun 2007
Urologix Receives CE Mark for CoolMax(TM) Microwave Catheter
Devices Urology Regulatory
 HSMN NewsFeed - 22 Jun 2007
Ranbaxy Receives Tentative Approval for Tamsulosin Capsules
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 21 Jun 2007
Celsion Completes Sale of Prolieve Assets
Devices Acquisitions Urology
 HSMN NewsFeed - 21 Jun 2007
Boston Scientific Purchases Prostate Treatment Technology from Celsion Corporation
Devices Acquisitions Urology
 HSMN NewsFeed - 18 Jun 2007
Medtronic Receives FDA Approval for New Tripolar, 16-Electrode Neurostimulation Lead to Treat Chronic Pain
Devices FDA
 HSMN NewsFeed - 14 Jun 2007
American Medical Systems Expands Global Clinical Evaluation of MiniArc(TM) Single Incision Sling for Female Stress Urinary Incontinence
Devices Urology
 HSMN NewsFeed - 18 May 2007
American Medical Systems Announces the Introduction of the TherMatrx TMX3000(TM) Office Thermo Therapy System
Devices Urology FDA
 HSMN NewsFeed - 16 May 2007
Lumenis Launches 'The Power of One' for VersaPulse(R) PowerSuite(TM) at American Urology Association 2007 Annual Meeting
Devices Urology
 HSMN NewsFeed - 8 May 2007
AEterna Zentaris Regains Exclusive Worldwide (ex-Japan) Rights from Solvay for Cetrorelix in Endometriosis Indication
Biopharmaceuticals
 HSMN NewsFeed - 7 May 2007
Nymox Announces New Positive Results from 3 1/2 Year Study of NX-1207 for Benign Prostatic Hyperplasia
Biopharmaceuticals Urology
 HSMN NewsFeed - 19 Apr 2007
AEterna Zentaris Reports First Patients Treated with Cetrorelix for Phase 3 Program in BPH
Biopharmacetuicals Urology
 HSMN NewsFeed - 18 Apr 2007
Celsion Announces Boston Scientific Exercises Its Option to Purchase Prolieve(R) Assets
Devices Urology Acquisitions
 HSMN NewsFeed - 17 Apr 2007
Cook Medical Launches Full Line of Resection Electrodes Enabling Urologists to Improve Prostate Health
Devices Urology
 HSMN NewsFeed - 27 Mar 2007
Protox Announces Senior Management Changes
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 22 Mar 2007
Bentley Announces Approval for Tamulosin in Spain
Biopharmaceuticals Generics Regulatory
 HSMN NewsFeed - 22 Mar 2007
American Medical Systems Has Initiated a Clinical Evaluation for a New Minimally Invasive Sling Intended to Treat Female Stress Urinary Incontinence
Devices Urology FDA
 HSMN NewsFeed - 19 Mar 2007
Nymox Announces Positive Results from Newly Completed Long-term Study of NX-1207 for Benign Prostatic Hyperplasia
Biopharmaceuticals Urology
 HSMN NewsFeed - 14 Mar 2007
Celsion Expands Board, Appoints New Independent Director
Biopharmaceuticals Drug Delivery Oncology Personnel
 HSMN NewsFeed - 14 Feb 2007
Light Sciences Oncology Initiates Phase II Trial of Litx(TM) Therapy in Patients with Glioma
Biopharmaceuticals Devices Drug Delivery Oncology
 HSMN NewsFeed - 8 Feb 2007
Celsion and AMS Settle Patent Dispute
Devices Licensing Litigation
 HSMN NewsFeed - 8 Feb 2007
American Medical Systems Announces Settlement with Celsion Corporation
Devices Licensing Litigation
 HSMN NewsFeed - 31 Jan 2007
Study of Trimedyne's New Side Firing Laser Fiber Shows Faster Tissue Vaporization Results
Devices Urology
 HSMN NewsFeed - 30 Jan 2007
Barr Launches Generic PROSCAR(R) Tablets, 5 mg
Biopharmaceuticals Generics
 HSMN NewsFeed - 30 Jan 2007
Light Sciences Oncology Receives Special Protocol Assessment for Pivotal Phase III Trial of Litx(TM) Therapy in Metastatic Colorectal Cancer
Devices Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 16 Jan 2007
Watson Announces Positive Phase 3 Study Results on Silodosin for Treatment of Benign Prostatic Hyperplasia
Biopharmaceuticals Urology
 HSMN NewsFeed - 8 Jan 2007
AEterna Zentaris Initiates First Study of Phase 3 Program with Cetrorelix in BPH - 600 Patient Trial Conducted in the United States and Canada
Biopharmaceuticals Urology
 HSMN NewsFeed - 18 Dec 2006
ICOS Announces Revised Merger Agreement With Lilly
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 13 Dec 2006
Trimedyne Raises $3 Million to Finance an Expected Increase in Sales of New Laser Fiber
Devices
 HSMN NewsFeed - 12 Dec 2006
American Medical Systems Appoints Mark A. Heggestad as Chief Financial Officer
Devices Personnel
 HSMN NewsFeed - 27 Nov 2006
AngioDynamics Announces FDA Clearance for Irreversible Electroporation Technology
Devices Cardiology FDA
 HSMN NewsFeed - 10 Nov 2006
Study Reports GYNECARE THERMACHOICE III Helps Most Women With Heavy Periods Return to Normal or Less Bleeding
Devices
 HSMN NewsFeed - 31 Oct 2006
Ablatherm-HIFU Launches a New RPP Site in Spain; RPP Service Available in Madrid at ICUA Clinic
Devices Urology Oncology
 HSMN NewsFeed - 17 Oct 2006
AngioDynamics to Acquire Oncobionic and Its Revolutionary New Cancer Therapy
Devices Oncology Interventional Mergers & Acquisitions
 HSMN NewsFeed - 17 Oct 2006
ICOS Corporation Announces Agreement to be Acquired by Eli Lilly and Company
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 3 Oct 2006
Spectrum Pharmaceuticals Announces Positive Phase 2 Data with Ozarelix in Patients with Benign Prostatic Hypertrophy
Biopharmaceuticals Urology
 HSMN NewsFeed - 3 Oct 2006
AEterna Zentaris Announces Positive Phase 2 Results for Ozarelix in Benign Prostatic Hyperplasia
Biopharmaceuticals Urology
 HSMN NewsFeed - 29 Sep 2006
Urologix Names Elissa J. Lindsoe as Chief Financial Officer
Devices Urology Personnel
 HSMN NewsFeed - 15 Sep 2006
ETHICON Introduces New, Advanced Device for Laparoscopic Hysterectomy
Devices Surgery
 HSMN NewsFeed - 12 Jul 2006
Medicure Appoints Vice President of Research and Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 5 Jul 2006
HSR Waiting Period Expires in American Medical Systems' Proposed Acquisition of Laserscope
Devices Mergers & Acquisitions
 HSMN NewsFeed - 28 Jun 2006
SurModics and AbbeyMoor Medical to Jointly Develop Drug-Device Convergence Products to Treat Diseases of the Prostate
Devices Urology
 HSMN NewsFeed - 23 Jun 2006
Dr. Reddy's launches authorized generic versions of Proscar(R) and Zocor(R)
Biopharmaceuticals Generics
 HSMN NewsFeed - 22 May 2006
Medtronic to Pursue Pivotal Trials of Treatments for Overactive Bladder and Enlarged Prostate
Devices Urology
 HSMN NewsFeed - 22 May 2006
Medtronic Launches PROSTIVA(TM) RF Therapy System, Proven Treatment Option for Enlarged Prostate
Devices Urology
 HSMN NewsFeed - 19 May 2006
Boston Scientific and Lumenis to Market Trimedyne's New Fiber
Devices Urology
 HSMN NewsFeed - 19 May 2006
Lumenis Announces Host of AUA 2006 Activities and Preview of New Breakthrough Laser Fiber for BPH Treatment
Devices Urology
 HSMN NewsFeed - 16 May 2006
Nymox Reports Positive New Efficacy Data for Benign Prostatic Hyperplasia Drug
Biopharmaceuticals Urology FDA
 HSMN NewsFeed - 9 May 2006
American Medical Systems Acquires Solarant Medical in Targeting Office-Based Stress Urinary Incontinence Solutions
Devices Mergers & Acquisitions
Return to NewsFeed  

 Additional items found! 186

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 186 additional stories matching:
Benign Prostatic Hyperplasia
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.